Management of hypertension in patients with diabetes: the place of angiotensin-II receptor blockers-Reference-Cited by-同舟云学术

Management of hypertension in patients with diabetes: the place of angiotensin-II receptor blockers

Published:2009-08 Issue:8 Volume:11 Page:757-769
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:

Author:

Kalaitzidis Rigas,Bakris George

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1463-1326.2009.01052.x/fullpdf

Reference79 articles.

1. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000;Ford;N Engl J Med,2007

2. Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study;Fox;Circulation,2007

3. Prevalence of hypertension among diabetic patients and its relation to vascular risk. Diabetes Hypertension Study Group;Fuller;J Hum Hypertens,1991

4. Hypertension in Diabetes Study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications;J Hypertens,1993

5. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure;Arch Intern Med,1997

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, Synthesis, and Biological Evaluation of 6-Benzoxazole Benzimidazole Derivatives with Antihypertension Activities;ACS Medicinal Chemistry Letters;2018-12-31

2. Hepatocyte growth factor exerts beneficial effects on mice with type II diabetes‑induced chronic renal failure via the NF‑κB pathway;Molecular Medicine Reports;2018-07-19

3. Resveratrol provides benefits in mice with type II diabetes‑induced chronic renal failure through AMPK signaling pathway;Experimental and Therapeutic Medicine;2018-05-17

4. Low annual frequency of HbA1ctesting in people with Type 2 diabetes in primary care practices in Germany;Diabetic Medicine;2017-12-13

5. Design, synthesis and evaluation of novel potent angiotensin II receptor 1 antagonists;European Journal of Medicinal Chemistry;2016-11